U.S., June 25 -- An application to own the trademark for 'ONYDA XR' has been filed on Aug. 14, 2024.
Owner(s):
TRIS PHARMA, INC.; 2031 US Highway 130, ATTN: General Counsel, NEW JERSEY
Goods and/or Services:
For: Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmaceutical preparations containing clonidine for treatment of attention deficit hyperactivity disorder
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
https://eog-tmng.uspto.gov/#/issueDate=2025-06-24&serialNumber=98698414
Disclaimer: Curated by HT Syndication....